Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
高级检索
  • AMILORIDE TREATMENT AMELIORATE...
  • 引用
  • 发送短信
  • 推荐此
  • 打印
  • 导出纪录
    • 导出到 RefWorks
    • 导出到 EndNoteWeb
    • 导出到 EndNote
  • Permanent link
AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

书目详细资料
Main Authors: Arun, T, Sbdarella, E, Ruiter, M, Tomassini, V, Leite, M, Craner, M, Fugger, L, Jenkinson, M, Palace, J
格式: Conference item
出版: 2012
  • 持有资料
  • 实物特征
  • 相似书籍
  • 职员浏览

相似书籍

  • ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride
    由: Arun, T, et al.
    出版: (2013)
  • Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride
    由: Arun, T, et al.
    出版: (2013)
  • Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
    由: Arun, T, et al.
    出版: (2013)
  • AMILORIDE CLINICAL TRIAL IN OPTIC NEURITIS: TRIAL PARADIGM
    由: McKee, J, et al.
    出版: (2014)
  • COMPARING MRI MEASURES OF MYELIN INTEGRITY AS SURROGATE MARKERS FOR THE CLINICAL EXPRESSION OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
    由: Matthews, L, et al.
    出版: (2010)

检索选项

  • 检索历史
  • 高级检索

查找更多

  • 浏览目录
  • 按字母顺序浏览
  • 探索频道
  • 课程储备
  • 新项目

需要帮助?

  • 检索技巧
  • 咨询台
  • 常见问题